Researchers at Tel Aviv University have made a significant breakthrough in heart surgeries by way of an injected protein that is capable of regrowing blood vessels in the human heart.
Researchers at Tel Aviv University have made a significant breakthrough in heart surgeries by way of an injected protein that is capable of regrowing blood vessels in the human heart. This development may one day relegate the need for bypass surgeries
In heart disease, blood vessels are either clogged or die off, starving the heart of oxygen and leaving it highly susceptible to a cardiac attack.
Bypass Surgery Not Linked to Long-Term Cognitive Decline in Patients
Contrary to previous study results, coronary bypass surgery is not responsible for long-term cognitive decline in patients, suggests a new study.
Contrary to previous study results, coronary bypass surgery is not responsible for long-term cognitive decline in patients, suggests a new study.
The new vessels in the heart could give millions of people around the world a new lease on life.
"The biotechnology behind our human-based protein therapy is very complicated, but the goal is simple and the solution is straightforward. We intend to inject our drug locally to heal any oxygen-starved tissue. So far in animal models, we've seen no side effects and no inflammation following our injection of the drug into the legs. The growth of new blood vessels happens within a few weeks, showing improved blood circulation," said Hardy.
Bypass Surgery, Drug-eluting Stents Possess Similar Risk and Outcome
Drug-eluting stent therapy and bypass surgery for coronary artery disease have about the same risk for a major cardiac event within 30 days after the procedures.
Drug-eluting stent therapy and bypass surgery for coronary artery disease have about the same risk for a major cardiac event within 30 days after the procedures.
"We could coat a stent with our peptide, attracting endothelial stem cells to form a film on the surface of the stent. These endothelial cells on the stent would eliminate the need for taking the blood thinners that prevent blood clots from forming," said Hardy.
Advertisement
Study Finds Stents as Effective as Bypass Surgery
Coronary stents are just as effective as bypass operations in extending longevity for patients with the most dangerous form of heart disease, a new study has found.
Coronary stents are just as effective as bypass operations in extending longevity for patients with the most dangerous form of heart disease, a new study has found.
The researchers began the study for preventing leg amputations, positing that proteins from the human body could be used to trigger the growth of new blood vessels.
Advertisement
Blacks Get Treatment on Par With Whites for Cardiovascular Disease
Health outcomes for blacks with cardiovascular disease are similar or better than those of whites when differences in access and treatment are minimized.
Health outcomes for blacks with cardiovascular disease are similar or better than those of whites when differences in access and treatment are minimized.
She then took some of the isolated and synthesized peptides and tested them in diabetic mice whose legs were in the process of dying.
Although diabetes is known to decrease blood circulation, Hardy found that her therapy reversed the decrease.
"Within a short time we saw the formation of capillaries and tiny blood vessels. After three weeks, they had grown and merged together with the rest of the circulatory system," she said.
In mice with limited blood circulation, she was able to completely restore blood vessels and save their legs.
It was then a short step to studying the applicability of the research to cardiac patients.
"It's pretty obvious if there is regrowth or not. Our technology promises to regrow blood vessels like a net, and a heart that grows more blood vessels becomes stronger. It's now imaginable that, in the distant future, peptide injections may be able to replace bypass surgeries," concluded Hardy.
The study has been published in Biochemical Pharmacology.
Source-ANI
SAV
